vortioxetine
Showing 26 - 50 of 110
Binge Eating Disorder Trial in Chicago (Vortioxetine, Placebo)
Completed
- Binge Eating Disorder
- Vortioxetine
- Placebo
-
Chicago, IllinoisUniversity of Chicago
Nov 19, 2020
MDD, Anxiety Disorders Trial in Worldwide (Vortioxetine)
Completed
- MDD
- Anxiety Disorders
- Vortioxetine
-
Tallinn, Estonia
- +20 more
Apr 19, 2021
Depressive Disorder, Major Trial in Worldwide (Vortioxetine)
Terminated
- Depressive Disorder, Major
- Vortioxetine
-
Tucson, Arizona
- +77 more
May 17, 2022
Depressive Disorder, Major Trial in Worldwide (Vortioxetine)
Completed
- Depressive Disorder, Major
- Vortioxetine
-
Targovishte, Bulgaria
- +30 more
Jun 22, 2021
Depressive Disorder, Major, Alcoholism Trial in Seoul (Vortioxetine, Acamprosate)
Unknown status
- Depressive Disorder, Major
- Alcoholism
- Vortioxetine
- Acamprosate
-
Seoul, Korea, Republic ofHanyang USH
Jul 30, 2020
Depressive Disorder, Major Trial in Worldwide (Vortioxetine 10 mg/day, Vortioxetine 20 mg/day, Fluoxetine 20mg/day)
Completed
- Depressive Disorder, Major
- Vortioxetine 10 mg/day
- +3 more
-
Little Rock, Arkansas
- +97 more
Aug 29, 2022
MDD Trial in Worldwide (Vortioxetine, Desvenlafaxine)
Completed
- Major Depressive Disorder
- Vortioxetine
- Desvenlafaxine
-
Banfield, Buenos Aires, Argentina
- +79 more
Feb 11, 2022
Age-related Cognitive Decline Trial in Saint Louis (Vortioxetine 10 mg, Cognitive training program)
Completed
- Age-related Cognitive Decline
- Vortioxetine 10 mg
- Cognitive training program
-
Saint Louis, MissouriWashington University School of Medicine
Dec 27, 2019
Vortioxetine for Cancer Depression: An Observational Study
Unknown status
- Major Depressive Disorder
- Cancer
- Vortioxetine
-
Ipoh, Perak, Malaysia
- +7 more
Jan 30, 2020
MDD Trial in Japan (Placebo, Vortioxetine)
Completed
- Major Depressive Disorder
- Placebo
- Vortioxetine
-
Nagoya, Aichi, Japan
- +46 more
Mar 3, 2021
Relapse, Cognitive Impairment, Depression Trial (Vortioxetine)
Unknown status
- Relapse
- +2 more
- Vortioxetine
- (no location specified)
Nov 26, 2019
Depressive Disorder, Major Depression, Depression Trial in Boston (Vortioxetine)
Terminated
- Depressive Disorder
- +3 more
- Vortioxetine
-
Boston, Massachusettsthe Massachusetts General Hospital
Sep 23, 2019
MDD Trial in Worldwide (Vortioxetine)
Completed
- Major Depressive Disorder
- Vortioxetine
-
Angoulême, France
- +22 more
Mar 23, 2020
MDD Trial in United States (Vortioxetine, Placebo)
Completed
- Major Depressive Disorder
- Vortioxetine
- Placebo
-
Phoenix, Arizona
- +78 more
Dec 16, 2020
Healthy Trial in Nottingham (Vortioxetine IV, Vortioxetine SLA, Vortioxetine SLB)
Completed
- Healthy
- Vortioxetine IV
- +3 more
-
Nottingham, United KingdomQuotient Sciences Ltd
Jul 30, 2019
Depressive Disorder, Major Trial in Worldwide (Vortioxetine 10 mg/day, Vortioxetine 20 mg/day, Fluoxetine 20 mg/day)
Completed
- Depressive Disorder, Major
- Vortioxetine 10 mg/day
- +3 more
-
Dothan, Alabama
- +123 more
Aug 4, 2020
MDD Trial in Bulgaria, Estonia, Latvia (Vortioxetine infusion 25 mg, Vortioxetine tablets 10 mg/day, Placebo infusion)
Completed
- Major Depressive Disorder
- Vortioxetine infusion 25 mg
- +3 more
-
Burgas, Bulgaria
- +12 more
Aug 28, 2019
Hoarding Disorder Trial in Hamilton (Vortioxetine Tablets)
Unknown status
- Hoarding Disorder
- Vortioxetine Tablets
-
Hamilton, Ontario, CanadaSt Joseph Healthcare
Jul 26, 2019
Depression, Type 2 Diabetes Trial (Vortioxetine, Sertraline)
Completed
- Depression
- Type 2 Diabetes Mellitus
- Vortioxetine
- Sertraline
- (no location specified)
Jun 11, 2019
Patient Engagement Trends in Anxiety Disorder Clinical Research
Not yet recruiting
- Anxiety Disorder
-
San Francisco, CaliforniaPower Life Sciences
Nov 24, 2023
Healthy Adult Participants Trial in Kumamoto (Vortioxetine)
Completed
- Healthy Adult Participants
- Vortioxetine
-
Kumamoto, JapanNishi Kumamoto Hospital
Jun 26, 2019
MDD Trial in United States (Vortioxetine)
Completed
- Major Depressive Disorder
- Vortioxetine
-
Costa Mesa, California
- +24 more
Jun 14, 2019
Prediction of Adolescents With MDD Response to ECT Via MRI
Recruiting
- Major Depressive Disorder
- +2 more
- Modified Electroconvulsive Therapy
- Conventional pharmacotherapy
-
Chongqing, Province, ChinaThe First Affiliated Hospital of Chongqing Medical University
May 26, 2023
The Antidepressant Advisor: fMRI Study to Predict Treatment
Completed
- Major Depressive Disorder
-
London, United KingdomKing's College London, IoPPN
Jan 4, 2023